We’re excited to have received a 3rd #FDAapproval of our first-in-class medicine! This approval is a welcomed development for #GERD patients, bringing a new treatment for heartburn relief in Non-Erosive GERD. Read more about what this means for the millions of people with this disease: https://bit.ly/4cLc2qe
Phathom Pharmaceuticals
Biotechnology Research
Florham Park, New Jersey 24,726 followers
Going beyond to advance treatments for patients with acid-related disorders
About us
Phathom Pharmaceuticals (Nasdaq: PHAT) is a biopharmaceutical company committed to transforming the treatment landscape for people suffering from gastrointestinal (GI) diseases related to acid. We are a team of highly driven pharmaceutical professionals who are passionate about our mission to address unmet needs for patients and improve their quality of life. By ensuring all voices are heard, holding ourselves accountable to be equitable and just, and authentically supporting the people and communities impacted by our work, we strive to create a sense of inclusion and belonging. We are looking for self-motivated, creative problem solvers who are excited by the idea of working in a fast-paced start-up environment and contributing to our growth.
- Website
-
http://phathompharma.com
External link for Phathom Pharmaceuticals
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Florham Park, New Jersey
- Type
- Public Company
- Founded
- 2018
- Specialties
- Biotechnology, Pharmaceuticals, R&D, Commercialization, Gastrointestinal , GI, Innovation, and Drug development
Locations
-
Primary
100 Campus Drive
Suite 102
Florham Park, New Jersey 07932, US
-
2150 E Lake Cook Rd
Suite 800
Buffalo Grove, Illinois 60089, US
-
70 Willow Rd
Suite 200
Menlo Park, California 94025, US
Employees at Phathom Pharmaceuticals
Updates
-
Our novel treatment is now #FDAapproved to relieve heartburn for adults with Non-Erosive GERD, the largest subset of #GERD. We’re excited to offer a new treatment option for the ~45 million adults in the U.S. living with this disease. Learn more about what this therapy means for the future of GERD treatment: https://bit.ly/4cLc2qe
-
We are pleased to share that CVS Caremark, the largest U.S. pharmacy benefit manager (PBM), has added our novel GERD therapy to their national commercial formularies. Today, over 116 million commercially covered lives have access to our novel treatment. Learn more about this #NEWS here: https://bit.ly/3LJrwPC
-
Join us on Thursday, August 8 at 8:30 AM ET for a live conference call with members of Phathom management to discuss our second quarter 2024 financial results and an update on recent business progress. Read more: https://bit.ly/3Wrcq6o
-
Happy National Intern Day 2024! 🎉 At Phathom, we are grateful for the contributions of our interns and love welcoming them into the #PhathomPhamily each summer. Your hard work, enthusiasm, and fresh perspectives are invaluable to our team. Thank you for your dedication! Swipe to see what our interns have been up to this summer ➡️ We’re also excited to be spotlighting interns from various departments at Phathom throughout the summer, who will share more about their experiences with the company and favorite #PHATMemories. Stay tuned! #NationalInternDay
-
Heading to #PriMedWest 2024? Stop by our booth (#613) to meet members of our team and learn more about our latest work. Be sure to check out our product theater on therapeutic options for the treatment of acid-related #GI disorders, happening Fri. July 19th at 11:35 AM PT in Industry Theater 2, Exhibit Hall D, Level 1. Hope to see you there! #GERD #PrimaryCare #PrimaryCareProvider #PCP #PriMedWest2024
-
Our #PhathomPhamily took the top spot once again in the International Foundation for Gastrointestinal Disorders (IFFGD)'s 2024 Virtual Digestive Health Wellness & Walk Event! Over 8 incredible days, #TeamPhathom embraced wellness challenges, prioritized physical and mental health, and logged over 13 MILLION steps – all to support #GIResearch. Congratulations to all participants and a big thank you to IFFGD for organizing another phantastic event! #PhathomStrong #LifeatPhathom
-
Whether you're watching fireworks with family, enjoying a barbecue with friends, or reflecting on our country's history and progress, we wish you a safe and happy #FourthofJuly from our #PhathomPhamily to yours! In observance of the holiday, Phathom’s offices will be closed tomorrow and Friday. #IndependenceDay
-
#DidYouKnow leaving H. pylori (HP) infection untreated may increase colorectal cancer (CRC) incidence and related mortality? A recently published study found that among an HP-positive population, individuals who received eradication treatment had reduced CRC incidence and related mortality compared to individuals who did not receive treatment for their HP infection. Learn more in the Journal of Clinical Oncology: https://bit.ly/3Rvon9l
-
On June 19, 1865, news of the Emancipation Proclamation reached Galveston, Texas, setting free more than 250,000 enslaved people. Each year we celebrate #Juneteenth as a powerful reminder of the long – still ongoing – journey towards #equality and freedom in the United States. Phathom’s offices will be closed this Friday to allow our team to reflect on and recognize the profound significance of this day. Together, we will continue to strive for equity and inclusion in all that we do. #DEI #Diversity